Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies

Launched by ADDARIO LUNG CANCER MEDICAL INSTITUTE · Jul 1, 2024

Keywords

ClinConnect Summary

This clinical trial, titled "Small Cell Lung Cancer Community Engagement to Eliminate Research Discrepancies," aims to improve how patients with small-cell lung cancer (SCLC) are engaged in clinical research. The study will explore if a remote approach, where patients can participate from home, can enhance outreach and support for those with SCLC. Researchers will also gather information about patients' preferences and needs regarding accessing new treatments, both in research settings and standard medical care, through surveys conducted at the start of the study and again after three months.

To be eligible for this study, participants must be at least 18 years old, able to communicate in English, and willing to share their medical information related to their cancer diagnosis. They should have a diagnosis of extensive stage SCLC or treated small-cell lung cancer. Participants will be asked to provide informed consent and comply with the study's requirements. It's important to note that individuals with uncontrolled health issues or those who have previously enrolled in this study cannot participate, but being involved in other clinical trials does not disqualify them. Overall, this trial seeks to create a better experience for patients by understanding their needs and improving access to treatments.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Men or women greater than or equal to 18 years of age at the time of consent
• • 2. Ability to read, write and communicate in English
• • 3. Provide voluntary consent to participate in this study, documented via a signed informed Consent Form (ICF)
• • 4. Willing to provide clinical and medical information related to his/her cancer diagnoses to the study team as required
• • 5. Willing to comply with the requirements of the study
• • 6. Diagnosis of extensive stage primary SCLC or tSCLC
• Exclusion Criteria:
• • 1. Known existence of an uncontrolled intercurrent illness including, but not limited to, psychiatric illness or social situations that would impair compliance with study requirements
• • 2. Subjects who previously enrolled to this study
• • Note: Concurrent enrollment in other clinical trials is NOT exclusionary